Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study

Inclusion Criteria: * Clinical criteria: 1. Age 19 years of older 2. Symptomatic peripheral artery disease: 1. Moderate or severe claudication (Rutherford category 2 or 3) 2. Critical limb ischemia (Rutherford category 4 or 5) 3. Patients with signed informed consent * Anatomical criteria: 1. Target lesion length ≥150 mm by angiographic estimation 2. Stenosis of more than 50% in femoropopliteal artery 3. At least one patent (less than 50 percent stenosed) tibioperoneal runoff vessel. Exclusion Criteria: * A. Clinical criteria 1. Acute critical limb ischemia 2. Severe critical limb ischemia (Rutherford category 6) 3. Major bleeding history within prior 2 months 4. Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel or contrast agents 5. Age \> 85 years 6. Severe hepatic dysfunction (\> 3 times normal reference values) 7. Significant renal dysfunction (Serum creatinine \> 2.0 mg/dl 8. Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis 9. LVEF(left ventricular ejection fraction) \<40% or clinically overt congestive heart failure 10. Pregnant women or women with potential childbearing 11. Life expectancy \<1 year due to comorbidity * Angiographic criteria 1. Previous bypass surgery or stenting of the superficial femoral artery 2. Untreated inflow disease of the ipsilateral pelvic arteries (more than 50%stenosis or or occlusion 3. Popliteal artery stenosis \>50% at P2 or P3 segment